Liquid biopsy of cell-free DNA (cfDNA) has attracted much attention for its promise to realize pan-cancer detection in a non-invasive way. The whole-genome bisulfite sequencing (WGBS) is widely used in cfDNA sequencing analysis and lays the foundation for further study on cfDNA. The cfDNA released by multiple tissues carries genetic and epigenetic information. Methylation patterns, copy number variation (CNV) and fragmentation changes have been discovered in previous studies and achieved a promising accuracy. In this review, different cancer detection methods based on these three biomarkers are introduced. In addition, feature fusion is discussed for its potential in enhancing performance in clinical applications
Pre-symptomatic screening of genetic alterations might help identify subpopulations of individuals t...
International audienceThe use of liquid biopsies for cancer detection and management is rapidly gain...
Detection of cellular changes in tissue biopsies has been the basis for cancer diagnostics. However,...
Liquid biopsy of cell-free DNA (cfDNA) has attracted much attention for its promise to realize pan-c...
Cell-free circulating DNA (cfDNA) in plasma has gained global interest as a diagnostic material for ...
Measuring the methylation status of cell-free DNA (cfDNA) in plasma holds great potential for the ea...
Widespread adaptation of liquid biopsy for the early detection of cancer has yet to reach clinical u...
Early detection of cancer saves lives, but an effective detection strategy in public health settings...
textabstractThe use of blood-circulating cell-free DNA (cfDNA) as 'liquid-biopsy' is explored worldw...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...
The increased importance of cancer genotyping in guiding cancer treatment has created a need for eff...
Cell-free DNA (cfDNA), acquired through non-invasive liquid biopsies, provides a new opportunity for...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
Analyzing cell-free DNA (cfDNA) as a source of circulating tumor DNA is useful for diagnosing or mon...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Pre-symptomatic screening of genetic alterations might help identify subpopulations of individuals t...
International audienceThe use of liquid biopsies for cancer detection and management is rapidly gain...
Detection of cellular changes in tissue biopsies has been the basis for cancer diagnostics. However,...
Liquid biopsy of cell-free DNA (cfDNA) has attracted much attention for its promise to realize pan-c...
Cell-free circulating DNA (cfDNA) in plasma has gained global interest as a diagnostic material for ...
Measuring the methylation status of cell-free DNA (cfDNA) in plasma holds great potential for the ea...
Widespread adaptation of liquid biopsy for the early detection of cancer has yet to reach clinical u...
Early detection of cancer saves lives, but an effective detection strategy in public health settings...
textabstractThe use of blood-circulating cell-free DNA (cfDNA) as 'liquid-biopsy' is explored worldw...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...
The increased importance of cancer genotyping in guiding cancer treatment has created a need for eff...
Cell-free DNA (cfDNA), acquired through non-invasive liquid biopsies, provides a new opportunity for...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
Analyzing cell-free DNA (cfDNA) as a source of circulating tumor DNA is useful for diagnosing or mon...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Pre-symptomatic screening of genetic alterations might help identify subpopulations of individuals t...
International audienceThe use of liquid biopsies for cancer detection and management is rapidly gain...
Detection of cellular changes in tissue biopsies has been the basis for cancer diagnostics. However,...